Niemann-pick C disease gene mutations and age-related neurodegenerative disorders

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zech, Michael ^a,b   Nübling, Georg ^d   Castrop, Florian ^a   Jochim, Angela ^a   Schulte, Eva C ^a,b   Mollenhauer, Brit ^e,i   Lichtner, Peter ^b,c   Peters, Annette ^b   Gieger, Christian ^b   Marquardt, Thorsten ^j   Vanier, Marie T ^k   Latour, Philippe ^k   Klünemann, Hans ^h   Trenkwalder, Claudia ^e,i   Diehl Schmid, Janine ^c   Perneczky, Robert ^c,f,g   Meitinger, Thomas ^b,c,l   Oexle, Konrad ^b,c   Haslinger, Bernhard ^a   Lorenzl, Stefan ^d   Winkelmann, Juliane ^a,b,c,l,m   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e PARACELSUS ELENA KLINIK   (Germany)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ UNIVERSITY OF GÖTTINGEN   (Germany)

^j UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^k HOSPICES CIVILS DE LYON   (France)

^l Stanford University School of Medicine ^*  (Germany)

^m STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE FACTORS; AGING; CARRIER PROTEINS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GLYCOPROTEINS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; NIEMANN-PICK DISEASES; PARKINSON DISEASE; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84893673648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082879     Document Type: Article

References (58)

1. Group N-CGW, Wraith JE, Baumgartner MR, Bembi B, Covanis A, et al. (2009) Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab 98: 152-165.
2. Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5: 16.
3. Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, et al. (2012) Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab 106: 330-344.
4. Vanier MT, Wenger DA, Comly ME, Rousson R, Brady RO, et al. (1988) Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients. Clin Genet 33: 331-348.
5. Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, et al. (2007) The adult form of Niemann-Pick disease type C. Brain 130: 120-133. (Pubitemid 46026228)
6. Klunemann HH, Elleder M, Kaminski WE, Snow K, Peyser JM, et al. (2002) Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2. Ann Neurol 52: 743-749. (Pubitemid 35403183)
7. Josephs KA, Van Gerpen MW, Van Gerpen JA (2003) Adult onset Niemann-Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry 74: 528-529. (Pubitemid 36379385)
8. Trendelenburg G, Vanier MT, Maza S, Millat G, Bohner G, et al. (2006) Niemann-Pick type C disease in a 68-year-old patient. J Neurol Neurosurg Psychiatry 77: 997-998. (Pubitemid 44174100)
9. Walterfang M, Fietz M, Fahey M, Sullivan D, Leane P, et al. (2006) The neuropsychiatry of Niemann-Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci 18: 158-170.
10. Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE (2007) Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol 6: 765-772. (Pubitemid 47238662)
11. Schicks J, Muller Vom Hagen J, Bauer P, Beck-Wodl S, Biskup S, et al. (2013) Niemann-Pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy. Neurology 80: 1169-1170.
12. Bauer P, Balding DJ, Klunemann HH, Linden DE, Ory DS, et al. (2013) Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Hum Mol Genet.
13. Zhang L, Sheng R, Qin Z (2009) The lysosome and neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai) 41: 437-445.
14. Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, et al. (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17: 119-129.
15. Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, et al. (2011) Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond. Mov Disord 26: 1593-1604.
16. Tofaris GK (2012) Lysosome-dependent pathways as a unifying theme in Parkinson's disease. Mov Disord 27: 1364-1369.
17. Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 19: 983-997.
18. Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, et al. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361: 1651-1661.
19. Gan-Or Z, Ozelius LJ, Bar-Shira A, Saunders-Pullman R, Mirelman A, et al. (2013) The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 80: 1606-1610.
20. Dehay B, Martinez-Vicente M, Caldwell GA, Caldwell KA, Yue Z, et al. (2013) Lysosomal impairment in Parkinson's disease. Mov Disord.
21. Brady OA, Zheng Y, Murphy K, Huang M, Hu F (2013) The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. Hum Mol Genet 22: 685-695.
22. Belcastro V, Siciliano V, Gregoretti F, Mithbaokar P, Dharmalingam G, et al. (2011) Transcriptional gene network inference from a massive dataset elucidates transcriptome organization and gene function. Nucleic Acids Res 39: 8677-8688.
23. Urwin H, Authier A, Nielsen JE, Metcalf D, Powell C, et al. (2010) Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet 19: 2228-2238.
24. Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, et al. (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43: 699-705.
25. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
26. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554.
27. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1-9. (Pubitemid 26243849)
28. Wichmann HE, Gieger C, Illig T, Group MKS (2005) KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl 1: S26-30.
29. van der Stoep N, van Paridon CD, Janssens T, Krenkova P, Stambergova A, et al. (2009) Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner. Hum Mutat 30: 899-909.
30. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
31. Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11: 863-874. (Pubitemid 32447869)
32. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7: 575-576.
33. Vanier MT, Rodriguez-Lafrasse C, Rousson R, Gazzah N, Juge MC, et al. (1991) Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim Biophys Acta 1096: 328-337.
34. Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93: 1288-1292.
35. Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, et al. (2010) Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med 2: 56ra81.
36. Jiang X, Sidhu R, Porter FD, Yanjanin NM, Speak AO, et al. (2011) A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 52: 1435-1445.
37. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl JMed 351: 1972-1977. (Pubitemid 39447138)
38. Sato C, Morgan A, Lang AE, Salehi-Rad S, Kawarai T, et al. (2005) Analysis of the glucocerebrosidase gene in Parkinson's disease. Mov Disord 20: 367-370. (Pubitemid 40613301)
39. Eblan MJ, Nguyen J, Ziegler SG, Lwin A, Hanson M, et al. (2006) Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov Disord 21: 282-283.
40. Tan EK, Tong J, Fook-Chong S, Yih Y, Wong MC, et al. (2007) Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch Neurol 64: 1056-1058. (Pubitemid 47048012)
41. Spitz M, Rozenberg R, Pereira Lda V, Reis Barbosa E (2008) Association between Parkinson's disease and glucocerebrosidase mutations in Brazil. Parkinsonism Relat Disord 14: 58-62.
42. Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, et al. (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 132: 1783-1794.
43. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, et al. (2010) Novel THAP1 sequence variants in primary dystonia. Neurology 74: 229-238.
44. Brown DE, Thrall MA, Walkley SU, Wurzelmann S, Wenger DA, et al. (1996) Metabolic abnormalities in feline Niemann-Pick type C heterozygotes. J Inherit Metab Dis 19: 319-330. (Pubitemid 26185524)
45. Yu W, Ko M, Yanagisawa K, Michikawa M (2005) Neurodegeneration in heterozygous Niemann-Pick type C1 (NPC1) mouse: implication of heterozygous NPC1 mutations being a risk for tauopathy. J Biol Chem 280: 27296-27302. (Pubitemid 41040770)
46. Josephs KA, Matsumoto JY, Lindor NM (2004) Heterozygous Niemann-Pick disease type C presenting with tremor. Neurology 63: 2189-2190. (Pubitemid 39636285)
47. Harzer K, Beck-Wodl S, Bauer P (2013) Niemann-Pick Disease Type C: New Aspects in a Long Published Family - Partial Manifestations in Heterozygotes. JIMD Rep.
48. Kluenemann HH, Nutt JG, Davis MY, Bird TD (2013) Parkinsonism syndrome in heterozygotes for Niemann-Pick C1. J Neurol Sci.
49. Rodriguez-Pascau L, Coll MJ, Vilageliu L, Grinberg D (2009) Antisense oligonucleotide treatment for a pseudoexon-generating mutation in the NPC1 gene causing Niemann-Pick type C disease. Hum Mutat 30: E993-E1001.
50. Rodriguez-Pascau L, Toma C, Macias-Vidal J, Cozar M, Cormand B, et al. (2012) Characterisation of two deletions involving NPC1 and flanking genes in Niemann-Pick type C disease patients. Mol Genet Metab 107: 716-720.
51. Tangemo C, Weber D, Theiss S, Mengel E, Runz H (2011) Niemann-Pick Type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storage. J Lipid Res 52: 813-825.
52. Sztolsztener ME, Strzelecka-Kiliszek A, Pikula S, Tylki-Szymanska A, Bandorowicz-Pikula J (2010) Cholesterol as a factor regulating intracellular localization of annexin A6 in Niemann-Pick type C human skin fibroblasts. Arch Biochem Biophys 493: 221-233.
53. Ribeiro I, Marcao A, Amaral O, Sa Miranda MC, Vanier MT, et al. (2001) Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations. Hum Genet 109: 24-32. (Pubitemid 32743190)
54. Sun X, Marks DL, Park WD, Wheatley CL, Puri V, et al. (2001) Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1. Am J Hum Genet 68: 1361-1372. (Pubitemid 32510612)
55. Greer WL, Dobson MJ, Girouard GS, Byers DM, Riddell DC, et al. (1999) Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain. Am J Hum Genet 65: 1252-1260. (Pubitemid 30460375)
56. Vanier MT, Millat G (2003) Niemann-Pick disease type C. Clin Genet 64: 269-281. (Pubitemid 37236127)
57. Park WD, O'Brien JF, Lundquist PA, Kraft DL, Vockley CW, et al. (2003) Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1. Hum Mutat 22: 313-325. (Pubitemid 37210856)
58. Chikh K, Rodriguez C, Vey S, Vanier MT, Millat G (2005) Niemann-Pick type C disease: subcellular location and functional characterization of NPC2 proteins with naturally occurring missense mutations. Hum Mutat 26: 20-28. (Pubitemid 40980699)